Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

PSTX Poseida Therapeutics Inc

9,31

-0,02 (-0,21%)

29 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Poseida Therapeutics (NASDAQ:PSTX)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Poseida Therapeutics Charts.

Poseida Therapeutics (NASDAQ:PSTX)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Poseida Therapeutics Charts.

News Poseida Therapeutics Inc

Form SC14D9C - Written communication relating to third party tender offer
Mittwoch 27 November 2024 (3 Tage vor) • Edgar (US Regulatory)

California-Based Biotech Trading over +200% Premarket Following Acquisition Announcement
Dienstag 26 November 2024 (4 Tage vor) • AllPennyStocks.com

Form SC14D9C - Written communication relating to third party tender offer
Dienstag 26 November 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 26 November 2024 (4 Tage vor) • Edgar (US Regulatory)

Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Dienstag 26 November 2024 (4 Tage vor) • PR Newswire (US)

Form 8-K - Current report
Donnerstag 14 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Poseida Therapeutics Hosts Cell Therapy R&D Day Highlighting Its Innovative Clinical and Preclinical Pipeline
Donnerstag 14 November 2024 (2 Wochen vor) • PR Newswire (US)

Poseida Therapeutics to Present at Two Upcoming Investor Conferences
Montag 11 November 2024 (3 Wochen vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (3 Wochen vor) • Edgar (US Regulatory)

Poseida Therapeutics Provides Updates and Financial Results for the Third Quarter of 2024
Donnerstag 7 November 2024 (3 Wochen vor) • PR Newswire (US)

Poseida Therapeutics to Present Clinical and Preclinical Data on Investigational Allogeneic CAR-T Cell Therapies at SITC 2024 and ASH 2024
Dienstag 5 November 2024 (3 Wochen vor) • PR Newswire (US)

Weitere Poseida Therapeutics Inc News-Artikel

Invesco QQQ Trust Series 1

Deutsche Telekom (QX)

Euro vs US Dollar

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen